Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III TrialC. Aschele, Luca Boni, Stefano Cordio et al.|Journal of Clinical Oncology|2011Cited by 763
Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and IrinotecanChiara Cremolini, Daniele Santini, Daniele Rossini et al.|JAMA Oncology|2018Cited by 418